*Source: Pediatric Dermatology Research Alliance (PeDRA).
View this sponsored webinar hosted in partnership with Abeona Therapeutics on cutting edge clinical development updates towards the treatment of epidermolysis bullosa. This webinar features presentations from Jean Tang, MD, PhD (Professor of Dermatology, Stanford University Medical Center and Principal Investigator, EB-101 pivotal Phase 3 VIITAL study) and Michael Amoroso (Chief Commercial Officer, Abeona) and moderated discussion. Recorded live on November 12, 2020.
Présentateurs
MD, Ph.D.
Jean Tang
Professeur de dermatologie, Stanford University Medical Center et chercheur principal, étude pivot VIITAL de phase 3 sur l’EB-101
Michael Amoroso
Directeur commercial, Abeona
